In an article from May 3, 2023, Bloomberg forecasts an annualized growth of 22.8 percent for

The National Institutes of Health (NIH) is a U.S. government agency with a proud history with

At the beginning of the year, CombiGene and Zyneyro entered into a collaboration for the development

In early 2023, CombiGene and the Danish company Zyneyro initiated a collaboration to jointly develop the

It is just over four months since CombiGene began the collaboration on the pain program COZY

Alvar Grönberg is Senior Program Director at CombiGene. He has a PhD from Karolinska Institutet (KI)

Odd-Geir Berge has previously, among many other things, worked as a Senior Principal Scientist, Analgesia at

Zyneyro was founded by a group of researchers from the Department of Neuroscience at the University

Pain costs a lot in the form of daily human suffering. There are also great financial

Pain is a complex area, not least because there are several different types of pain, and